Induction of CD8<sup>+</sup>T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant GliomaHideho Okada, Frank S. Lieberman|Journal of Clinical Oncology|2010Cited by 561
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomasGary Kohanbash, Hideho Okada|Journal of Clinical Investigation|2017Cited by 411
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapyZinal Chheda, Hideho Okada|The Journal of Experimental Medicine|2017Cited by 215
Inhibition of STAT3 Promotes the Efficacy of Adoptive Transfer Therapy Using Type-1 CTLs by Modulation of the Immunological Microenvironment in a Murine Intracranial GliomaMitsugu Fujita, Hideho Okada|The Journal of Immunology|2008Cited by 104
Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironmentRyusuke Hatae, Hideho Okada|JCI Insight|2024Cited by 39